{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:31:12Z","timestamp":1793421072115,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.etap.2026.105137","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:08:20Z","timestamp":1786946900000},"page":"105137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dapsone: strategies for increasing patient tolerance"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-6852","authenticated-orcid":false,"given":"Michael D.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2026.105137_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.md.0000141096.00377.3f","article-title":"Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals","volume":"83","author":"Ash-Bernal","year":"2004","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.etap.2026.105137_bib2","first-page":"97","article-title":"Antioxidant effect of different vitamins on methemoglobin production: an in vitro study","volume":"3","author":"Atyabi","year":"2012","journal-title":"Vet. Res. Forum"},{"key":"10.1016\/j.etap.2026.105137_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03016060","article-title":"Prophylactic methylene blue in a patient with congenital methemoglobinemia","volume":"52","author":"Baraka","year":"2005","journal-title":"Can. J. Anesth."},{"key":"10.1016\/j.etap.2026.105137_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1345\/aph.1Q139","article-title":"Dapsone-induced methemoglobinemia: a primer for clinicians","volume":"45","author":"Barclay","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.etap.2026.105137_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.toxrep.2024.03.004","article-title":"Causes of acquired methemoglobinemia \u2013 a retrospective study at a large academic hospital","volume":"12","author":"Belzer","year":"2024","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.etap.2026.105137_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-1557(199809\/10)7:5<319::AID-PDS367>3.0.CO;2-K","article-title":"Postmarketing surveillance of the safety of cimetidine: 15-year mortality report","volume":"7","author":"Beresford","year":"1998","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.etap.2026.105137_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0306-3623(96)00474-0","article-title":"The pharmacology of the antioxidant lipoic acid","volume":"29","author":"Biewenga","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib8","first-page":"2246","article-title":"Whole bowel irrigation in dapsone intoxication with persistent methemoglobinemia","volume":"38","author":"Bisso","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.etap.2026.105137_bib9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0009-9236(99)90081-4","article-title":"Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors","volume":"65","author":"Bluhm","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.etap.2026.105137_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0006-2952(92)90449-S","article-title":"Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone","volume":"44","author":"Bozeman","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib11","first-page":"958","article-title":"Dapsone-induced methemoglobinemia: case of the blue lady","volume":"59","author":"Burke","year":"2013","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.etap.2026.105137_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/lungindia.lungindia_160_18","article-title":"The girl with the \"saturation gap\"","volume":"35","author":"Chouksey","year":"2018","journal-title":"Lung India"},{"key":"10.1016\/j.etap.2026.105137_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1079-2104(99)70110-1","article-title":"A retrospective study of the management of oral mucous membrane pemphigoid with dapsone","volume":"88","author":"Ciarrocca","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.etap.2026.105137_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2133.1993.tb00476.x","article-title":"Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance","volume":"129","author":"Coleman","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.etap.2026.105137_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0306-3623(95)00029-1","article-title":"Dapsone toxicity: some current perspectives","volume":"26","author":"Coleman","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib16","series-title":"Human Drug Metabolism: An Introduction","first-page":"243","author":"Coleman","year":"2020"},{"key":"10.1016\/j.etap.2026.105137_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2165\/00002018-199614060-00005","article-title":"Drug-induced methaemoglobinaemia","volume":"14","author":"Coleman","year":"1996","journal-title":"Drug Saf."},{"key":"10.1016\/j.etap.2026.105137_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1382-6689(01)00080-1","article-title":"The therapeutic use of lipoic acid in diabetes: a current perspective","volume":"10","author":"Coleman","year":"2001","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.etap.2004.01.005","article-title":"The methaemoglobin forming and GSH depleting effects of dapsone and monoacetyl dapsone hydroxylamines in human diabetic and non-diabetic erythrocytes in vitro","volume":"17","author":"Coleman","year":"2004","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0006-2952(93)90246-S","article-title":"Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro","volume":"45","author":"Coleman","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2125.1992.tb04131.x","article-title":"The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients","volume":"34","author":"Coleman","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2125.1990.tb03847.x","article-title":"The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man","volume":"30","author":"Coleman","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1382-6689(03)00048-6","article-title":"Effects of dihydrolipoic acid (DHLA), a-lipoic acid. N-acetyl cysteine and ascorbate on xenobiotic-mediated methaemoglobin formation in human erythrocytes in vitro","volume":"14","author":"Coleman","year":"2003","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/14746514010010011601","article-title":"Monitoring antioxidant effects using methaemoglobin formation in diabetic erythrocytes","volume":"1","author":"Coleman","year":"2001","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"10.1016\/j.etap.2026.105137_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1152\/ajplegacy.1942.137.1.56","article-title":"The effect of methemoglobin on the equilibrium between oxygen and hemoglobin","volume":"137","author":"Darling","year":"1942","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.etap.2026.105137_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jlb.62.6.827","article-title":"Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction","volume":"62","author":"Debol","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.etap.2026.105137_bib27","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acsptsci.5c00204","article-title":"Alpha-lipoic acid reduces methemoglobin and oxidative imbalance in the blood and liver induced by dapsone in mice: molecular mechanism of antioxidant action","volume":"8","author":"dos Santos","year":"2025","journal-title":"ACS Pharmacol. Transnatl. Sci."},{"key":"10.1016\/j.etap.2026.105137_bib28","doi-asserted-by":"crossref","DOI":"10.5492\/wjccm.v14.i3.105350","article-title":"Methylene blue in the critical care setting","volume":"14","author":"Elmati","year":"2025","journal-title":"World J. Crit. Care Med."},{"key":"10.1016\/j.etap.2026.105137_bib29","unstructured":"FDA, 2017. Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications:https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-serious-cns-reactions-possible-when-methylene-blue-given-patients."},{"key":"10.1016\/j.etap.2026.105137_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","author":"Gong","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.etap.2026.105137_bib31","doi-asserted-by":"crossref","first-page":"e1025","DOI":"10.1111\/j.1365-2230.2009.03710.x","article-title":"The use of cimetidine to reduce dapsone-dependent haematological side-effects in a patient with mucous membrane pemphigoid","volume":"34","author":"Goolamali","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.etap.2026.105137_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s13181-023-00972-0","article-title":"Methylene blue-induced serotonin toxicity: case files of the medical toxicology fellowship at the New York city Poison Control Center","volume":"20","author":"Hazekamp","year":"2024","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.etap.2026.105137_bib33","first-page":"1029","article-title":"Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model","volume":"29","author":"Hutzler","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.etap.2026.105137_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0090-9556(25)07293-9","article-title":"Metabolic interactions of putativecytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes","volume":"24","author":"Irshaid","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl. 1","key":"10.1016\/j.etap.2026.105137_bib35","first-page":"S93","article-title":"Methemoglobinemia \u2013 a case report and literature review","volume":"61","author":"Ivek","year":"2022","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.etap.2026.105137_bib36","doi-asserted-by":"crossref","first-page":"E1062","DOI":"10.1503\/cmaj.212015","article-title":"Methemoglobinemia in a 28-year-old woman treated with dapsone","volume":"194","author":"Jacob","year":"2022","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.etap.2026.105137_bib37","article-title":"Concurrent administration of methylene blue and a selective serotonin reuptake inhibitor: a recipe for serotonin syndrome","volume":"13","author":"Johnson","year":"2012","journal-title":"JICS e"},{"key":"10.1016\/j.etap.2026.105137_bib38","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1378\/chest.10-2908","article-title":"Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret","volume":"140","author":"Kanoh","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.etap.2026.105137_bib39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/0006-2952(91)90565-M","article-title":"Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs","volume":"41","author":"Kettle","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40001-025-03427-0","article-title":"Efficacy and safety of dapsone in adult immune thrombocytopenia: a systematic review and meta-analysis","volume":"31","author":"Khan","year":"2026","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.etap.2026.105137_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<251::AID-AJH10>3.0.CO;2-M","article-title":"Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura","volume":"62","author":"Le Lou\u00ebt","year":"1999","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.etap.2026.105137_bib42","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3390\/ijms21175953","article-title":"4,4-Diaminodiphenyl sulfone (DDS) as an inflammasome competitor","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.etap.2026.105137_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035062","article-title":"Whether long-term use of proton pump inhibitor increases the risk of precancerous lesions in the stomach: a systematic review and meta-analysis of randomized controlled trials","volume":"102","author":"Lv","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.etap.2026.105137_bib44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2044.2007.05332.x","article-title":"Cimetidine and dapsone mediated methaemoglobinaemia","volume":"62","author":"Mehta","year":"2007","journal-title":"Anaesthesia"},{"key":"10.1016\/j.etap.2026.105137_bib45","doi-asserted-by":"crossref","first-page":"A1527","DOI":"10.1016\/j.chest.2019.08.1350","article-title":"Dapsone-induced methemoglobinemia treated with oral cimetidine: a case report","volume":"156","author":"Millet","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.etap.2026.105137_bib46","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jid.2021.04.009","article-title":"Dapsone suppresses disease in preclinical murine models of pemphigoid diseases","volume":"141","author":"Murthy","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.etap.2026.105137_bib47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11845-008-0176-5","article-title":"A case of dapsone induced methaemoglobineamia","volume":"177","author":"O\u2019Dwyer","year":"2008","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.etap.2026.105137_bib48","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3201\/eid2609.202353","article-title":"Methemoglobinemia in patient with G6PD deficiency and SARS-CoV-2 infection","volume":"26","author":"Palmer","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.etap.2026.105137_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3332\/ecancer.2014.485","article-title":"Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.etap.2026.105137_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5530\/ijper.20266059","article-title":"Development and Assessment of Mucoadhesive Buccal Tablets Containing Dapsone: A Pharmaceutical Innovation","volume":"60","author":"Parameshwar","year":"2026","journal-title":"Indian J Pharm. Educ. Res."},{"key":"10.1016\/j.etap.2026.105137_bib51","series-title":"StatPearls","article-title":"Aromatase inhibitors","author":"Peters","year":"2025"},{"key":"10.1016\/j.etap.2026.105137_bib52","unstructured":"Pino, M.A., Patel, P. Cimetidine. 2026. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544255\/."},{"key":"10.1016\/j.etap.2026.105137_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/molecules30010113","article-title":"Dapsone alters phenotypical and functional properties of human neutrophils in vitro","volume":"30","author":"Rakocevic","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.etap.2026.105137_bib54","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.bjp.0707430","article-title":"Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction","volume":"152","author":"Ramsay","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40257-020-00584-2","article-title":"Dermatitis herpetiformis: an update on diagnosis and management","volume":"22","author":"Reunala","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.etap.2026.105137_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2133.1995.tb05022.x","article-title":"Cimetidine improves the therapeutic\/toxic ratio of dapsone in patients on chronic dapsone therapy","volume":"132","author":"Rhodes","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.etap.2026.105137_bib57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ccm.0000729416.23584.ed","article-title":"Use of cimetidine to reduce dapsone-induced toxicity in a non-G-6-deficient transplant patient","volume":"49","author":"Rouse","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.etap.2026.105137_bib58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/biom9080356","article-title":"Insights on the use of \u03b1-Lipoic acid for therapeutic purposes","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.etap.2026.105137_bib59","doi-asserted-by":"crossref","DOI":"10.5070\/D33S15Q645","article-title":"Cimetidine: a review of the recent developments and reports in cutaneous medicine","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.etap.2026.105137_bib60","first-page":"399","article-title":"The diagnosis and treatment of autoimmune blistering skin diseases","volume":"108","author":"Schmidt","year":"2011","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.etap.2026.105137_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000431171","article-title":"Dapsone therapy for pustular psoriasis:case series and review of the literature","volume":"232","author":"Sheu","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.etap.2026.105137_bib62","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3399\/bjgp22X718769","article-title":"Pulse oximetry in primary care: factors affecting accuracy and interpretation","author":"Silverston","year":"2022","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.etap.2026.105137_bib63","series-title":"Comprehensive Dermatologic Drug Therapy (Fourth Edition)","first-page":"366","article-title":"Comprehensive dermatologic drug therapy 34 - antiandrogens and androgen inhibitors","author":"Somani","year":"2021"},{"key":"10.1016\/j.etap.2026.105137_bib64","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-2125.1990.tb05448.x","article-title":"Investigation into the role of metabolism in dapsone-induced methaemoglobinaemia using a two-compartment in vitro test system","volume":"30","author":"Tingle","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2125.1991.tb05623.x","article-title":"The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes","volume":"32","author":"Tingle","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2026.105137_bib66","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.12718","article-title":"Toxic methemoglobinemia treated with ascorbic acid: case report","volume":"15","author":"Topal","year":"2013","journal-title":"Iran. Red. Crescent Med. J."},{"issue":"11","key":"10.1016\/j.etap.2026.105137_bib67","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jamadermatol.2016.2303","article-title":"Novel treatment using cimetidine for erythropoietic protoporphyria in children","volume":"152","author":"Tu","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.etap.2026.105137_bib68","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-3565(25)22309-6","article-title":"Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells","volume":"245","author":"Uetrecht","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.etap.2026.105137_bib69","first-page":"149","article-title":"Dapsone-associated methemoglobinemia treated with cimetidine: a case report","volume":"75","author":"von den Baumen","year":"2022","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.etap.2026.105137_bib70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/jamainternmed.2024.7932","article-title":"Benzocaine-induced methemoglobinemia after nasogastric tube insertion","volume":"185","author":"Williams","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.etap.2026.105137_bib71","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0090-9556(24)15155-0","article-title":"CYP2C8\/9 mediates dapsone N-hydroxylation at clinical concentrations of dapsone","volume":"28","author":"Winter","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.etap.2026.105137_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","article-title":"Dapsone in dermatology and beyond","volume":"306","author":"Wozel","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.etap.2026.105137_bib73","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s000110050215","article-title":"Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study","author":"Wozel","year":"1997","journal-title":"Inflamm. Res. 46"},{"key":"10.1016\/j.etap.2026.105137_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2025.104644","article-title":"Cimetidine (H2 histamine antagonist), Fexofenadine (H1 histamine antagonist), and Zinc sulphate in the treatment of erythropoietic protoporphyria","volume":"53","author":"Wulf","year":"2025","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.etap.2026.105137_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12746\/swrccc.v2i5.109","article-title":"Drug-induced methemoglobinemia: a case report and review of literature","volume":"2","author":"Zedan","year":"2014","journal-title":"SWRCCC"},{"key":"10.1016\/j.etap.2026.105137_bib76","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/all.13769","article-title":"Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B*13:01","volume":"74","author":"Zhao","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.etap.2026.105137_bib77","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000001930","article-title":"Treatment of dapsone-induced methemoglobinemia in a transplant recipient with isosulfan blue allergy","volume":"12","author":"Zhao","year":"2025","journal-title":"ACG Case Rep. J."},{"key":"10.1016\/j.etap.2026.105137_bib78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003088-198611040-00003","article-title":"Clinical pharmacokinetics of dapsone.","volume":"11","author":"Zuidema","year":"1986","journal-title":"Clin. Pharmacokinet."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668926002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668926002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:01:38Z","timestamp":1793419298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668926002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":78,"alternative-id":["S1382668926002152"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2026.105137","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapsone: strategies for increasing patient tolerance","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2026.105137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105137"}}